Last Posted: May 21, 2020
- Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing.
Xiang Hongyu et al. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2020 Apr 32(2) 163-174 - Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
Zhao Shen et al. The oncologist 2020 May - Population-based Genetic Testing for Precision Prevention.
Evans Olivia et al. Cancer prevention research (Philadelphia, Pa.) 2020 May - PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer.
Alfarsi Lutfi H et al. BMC cancer 2020 May 20(1) 425 - 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina.
Bešlija Semir et al. Bosnian journal of basic medical sciences 2020 May - An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program.
Tran Quyen et al. Journal of the National Cancer Institute. Monographs 2020 May 2020(55) 72-81 - Classification of Breast Cancer Cells Using the Integration of High-Frequency Single-Beam Acoustic Tweezers and Convolutional Neural Networks.
Lim Hae Gyun et al. Cancers 2020 May 12(5) - Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features.
Yang Xiaojun et al. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2020 Apr 32(2) 175-185 - Expanding the landscape of actionable genomic alterations in metastatic breast cancer: comprehensive genomic profiling for all?
Hilbers F S et al. Annals of oncology : official journal of the European Society for Medical Oncology 2020 May - Fertility preservation in patients with BRCA mutation.
Ghunaim Suleiman et al. Ecancermedicalscience 2020 141033
.png)
No hay comentarios:
Publicar un comentario